13.01.2011 • NewsThermo FisherGoldman Sachsportfolio

Thermo Fisher To Pursue Sale Of Lab-Testing Units

Thermo Fisher Scientific, a maker of scientific instruments, is pursuing a sale of two lab-testing divisions that may fetch up to $1 billion, Bloomberg said, citing three people familiar with the matter.

Thermo Fisher has hired Goldman Sachs to handle the sale of Athena Diagnostics, which may be sold for $600-$700 million, and Barclays Capital to help it sell Lancaster Labs, which may fetch $200-$300 million, Bloomberg said.

In December, Thermo Fisher agreed to buy Dionex Corp for $2.1 billion to broaden its lab equipment and environmental safety offerings and boost its presence in Asia.

Thermo Fisher was not immediately available for comment outside of regular U.S. business hours.

Company

Logo:

Thermo Fisher Scientific

81 Wyman Street
02454 Waltham, MA
US

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.